Published in Drug Week, May 6th, 2005
The NDA is based on positive results of four double-blind, randomized, placebo-controlled studies of Nuvigil in patients with excessive sleepiness associated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.